Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T16:26:34.073Z.
Calculation as of: 2026-10-06T16:26:34.073Z.
Quote observation: 2026-10-06T16:25:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Bright Minds Biosciences Inc.
Market Cap
$469.98M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$467.38M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$473.09M
Operating Cash Flow Yield
7.61%
TTM Avg
6.58%
3Y Avg
6.94%
5Y Avg
6.76%
Market Cap
$473.84M
Operating Cash Flow Yield
N/A
TTM Avg
4.04%
3Y Avg
4.04%
5Y Avg
4.04%
Market Cap
$474.59M
Operating Cash Flow Yield
0.51%
TTM Avg
0.89%
3Y Avg
1.82%
5Y Avg
1.82%
Market Cap
$479.07M
Operating Cash Flow Yield
N/A
TTM Avg
18.97%
3Y Avg
18.89%
5Y Avg
14.32%
Market Cap
$456.82M
Operating Cash Flow Yield
6.46%
TTM Avg
6.70%
3Y Avg
7.02%
5Y Avg
5.84%
Market Cap
$486.85M
Operating Cash Flow Yield
8.45%
TTM Avg
13.05%
3Y Avg
17.35%
5Y Avg
16.73%
Market Cap
$449.00M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $469.98M | N/A | N/A | N/A | N/A |
| Sight Sciences, Inc. (SGHT)vs › | $467.38M | N/A | N/A | N/A | N/A |
| Kamada Ltd. (KMDA)vs › | $473.09M | 7.61% | 6.58% | 6.94% | 6.76% |
| Contineum Therapeutics, Inc. (CTNM)vs › | $473.84M | N/A | 4.04% | 4.04% | 4.04% |
| Cerus Corporation (CERS)vs › | $474.59M | 0.51% | 0.89% | 1.82% | 1.82% |
| Arvinas, Inc. (ARVN)vs › | $479.07M | N/A | 18.97% | 18.89% | 14.32% |
| NRC Health (NRC)vs › | $456.82M | 6.46% | 6.70% | 7.02% | 5.84% |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.85M | 8.45% | 13.05% | 17.35% | 16.73% |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $449.00M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $447.94M | N/A | 52.36% | 52.36% | 52.36% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
